Skip to content

A multi-centre randomised controlled clinical study of the "Huoxuesanfeng" acupuncture method for the treatment of essential hypertension

A multi-centre randomised controlled clinical study of the "Huoxuesanfeng" acupuncture method for the treatment of essential hypertension

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084696
Enrollment
Unknown
Registered
2024-05-23
Start date
2024-05-30
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Acupuncture group:The patient was instructed to take the supine position, the skin of the acupoints was routinely sterilised, and then the fixation pads were pasted on each acupoint. People welcome, t
Hegu, Taichong points are vertically into the needle 20 ~ 25mm, Baihui in the direction of the Directing Vessel 10 ~ 20mm, line Shi Xuemin academician twisting tonic and diarrhoeal techniques in the d
Quchi, foot Sanli points are vertically into the needle 25 to 40mm, the academician Shi Xue-min twisting tonic and diarrhoeal techniques in the complementary method, that is, the doctor faces the pati
False needle group:The patient took the supine position, the local skin of the acupoints was disinfected routinely, and then the fixation pads were pasted on each acupoint. The non-acupuncture p

Sponsors

Dongzhimen Hospital of Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) 18 years old = 75 years old, both male and female. (2) Those who meet the diagnostic criteria of primary hypertension in the ISH2020 International Hypertension Practice Guidelines, with hypertension classified as grade 1 and low to medium risk; and those who receive acupuncture treatment without changing the original treatment; (3) Those whose blood pressure has not reached the standard even after maintaining the original treatment programme for 2 weeks; (4) The patients have a correct understanding of the significance of the clinical study, have good compliance with the observations and evaluations of the researchers, and have signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Secondary hypertension such as aldosteronism, pheochromocytoma, Cushing's syndrome, pregnancy hypertension, etc; (2) Patients with other serious cardiovascular, cerebrovascular, renal, retinal and peripheral vascular complications and diabetes mellitus, blood disorders that are not suitable for acupuncture treatment, combined with diagnosed epilepsy, obstructive sleep apnoea hypoventilation syndrome, etc; (3) People with mental disorders such as severe anxiety and depression; (4) Pregnant and lactating women; (5) Those who have received acupuncture treatment in the last month or are participating in other clinical trials.

Design outcomes

Secondary

MeasureTime frame
Dizziness handicap inventory;Headache Impact Test version 6;Pittsburgh Sleep Quality Index;the MOS item short fromhealth survey;

Primary

MeasureTime frame
24h ambulatory blood pressure;Immediate blood pressure in the office;

Countries

China

Contacts

Public ContactWang Jun

Dongzhimen Hospital of Beijing University of Chinese Medicine

1083541417@qq.com+86 188 0131 6550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026